Literature DB >> 32150451

Biological Regeneration of Articular Cartilage in an Early Stage of Compartmentalized Osteoarthritis: 12-Month Results.

Martina Schinhan1, Stefan Toegel2,3, Daniela Weinmann2, Eleonora Schneider1, Catharina Chiari1, Martin Gruber4, Stefan Nehrer5, Reinhard Windhager1.   

Abstract

BACKGROUND: Biological regeneration in an early stage of osteoarthritis (OA) is an important clinical challenge. An early-stage compartmentalized OA model was used to evaluate different biological regeneration techniques. HYPOTHESIS: Biological regeneration in an early stage of compartmentalized OA is possible. STUDY
DESIGN: Controlled laboratory study.
METHODS: A 7-mm cartilage defect was surgically created in 24 sheep. After 3 months, by which time early OA had set in, the sheep were randomized into 4 different treatment groups and operated for the second time. One group (CONTROL) served as a long-term follow-up group for the further development of OA. The other 3 groups (regeneration groups) each underwent a different regeneration procedure after abrasion of the subchondral bone (defect size: 20 × 10 mm with a depth of 2.5 mm): spongialization alone (SPONGIO), spongialization followed by implantation of an unseeded hyaluronan matrix (MATRIX), or spongialization followed by implantation of a hyaluronan matrix seeded with autologous chondrocytes (MACT). Then, 12 months after the second operative procedure, the animals were euthanized and the defects subjected to macroscopic and histological grading. Historical 4-month data were compared with the 12-month results.
RESULTS: After 12 months of follow-up, advanced cartilage degeneration was observed in the CONTROL group. On the other hand, all regeneration groups improved significantly compared with the 4-month results using the Mankin score. Cartilage quality in the MACT group was significantly better than in the MATRIX group, as determined by the Mankin and the O'Driscoll scores.
CONCLUSION: There are no existing clinical options for preventing early OA from progressing to a severe disease. This study provides important information on how a surgical intervention can forestall the development of OA. CLINICAL RELEVANCE: OA of the knee is very common. Total joint replacement is not an acceptable option for active patients. Biological regeneration in OA is successful for focal cartilage defects; however, a long-term follow-up for biological regeneration in OA is missing. It is essential to have long-term results for a regenerative procedure involving cartilage, which is a tissue with a very slow turnover.

Entities:  

Keywords:  articular cartilage; articular cartilage resurfacing; knee; osteoarthritis; regeneration; sheep model; tissue engineering

Mesh:

Substances:

Year:  2020        PMID: 32150451     DOI: 10.1177/0363546520906411

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  4 in total

1.  Bone marrow aspirate concentrate and scaffold for osteochondral lesions of the talus in ankle osteoarthritis: satisfactory clinical outcome at 10 years.

Authors:  Francesca Vannini; Giuseppe Filardo; Sante Alessandro Altamura; Emanuele Di Quattro; Laura Ramponi; Roberto Buda; Sandro Giannini; Cesare Faldini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-02-19       Impact factor: 4.342

2.  Evaluation of cartilage degeneration using multiparametric quantitative ultrashort echo time-based MRI: an ex vivo study.

Authors:  Hongda Shao; Jiawei Yang; Yajun Ma; Xiaolian Su; Guangyu Tang; Junjie Jiang; Jiang Du; Jianjun Liu
Journal:  Quant Imaging Med Surg       Date:  2022-03

Review 3.  Noncoding RNAs in subchondral bone osteoclast function and their therapeutic potential for osteoarthritis.

Authors:  Li Duan; Yujie Liang; Xiao Xu; Jifeng Wang; Xingfu Li; Deshun Sun; Zhiqin Deng; Wencui Li; Daping Wang
Journal:  Arthritis Res Ther       Date:  2020-11-25       Impact factor: 5.156

4.  CircHYBID regulates hyaluronan metabolism in chondrocytes via hsa-miR-29b-3p/TGF-β1 axis.

Authors:  Hong-Xing Liao; Zhi-Hui Zhang; Hui-Lin Chen; Ying-Mei Huang; Zhan-Liang Liu; Jian Huang
Journal:  Mol Med       Date:  2021-05-31       Impact factor: 6.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.